Home Access Health
This article was originally published in The Gray Sheet
Executive Summary
Premarket approval application for the company's Hepatitis C Check at-home telemedicine counseling and testing service, submitted in December, will receive an expedited and streamlined review from FDA, the firm states Feb. 19. The agency referenced the current Hepatitis C lookback program as one of the primary reasons for the move, according to Home Access ("The Gray Sheet" Dec. 21, In Brief)